The Low Glucose Suspend Trial - Comparing insulin pump therapy with low glucose suspend feature versus standard insulin pump therapy in patients with type 1 diabetes with hypoglycaemia unawareness

This study is comparing a newer insulin pump that automatically stops delivering insulin when blood sugar drops too low (called a 'low glucose suspend' feature) to a standard insulin pump in people with type 1 diabetes who have trouble sensing when their blood sugar is low. When people lose the ability to feel low blood sugar (a condition called hypoglycaemia unawareness), the automatic shut-off feature may prevent dangerous low blood sugar episodes. You may be eligible if: - You are between 4 and 50 years old - You have had diabetes for at least 12 months - You have been using an insulin pump for at least 6 months - Your HbA1c (average blood sugar measure) is between 6% and 8.5% - You have impaired awareness of low blood sugar (hypoglycaemia unawareness) You may NOT be eligible if: - You have adrenal insufficiency - You have growth hormone deficiency - You have multiple pituitary hormone deficiencies - You are pregnant Talk to your doctor about whether this trial might be right for you.